Non-recurring items to affect Stora Enso's Q4 operating profit negatively by €392M, with Printing and Reading having negative allocation of €538M, partially offset by positive allocation of €144M in Renewable Packaging

Debra Garcia

Debra Garcia

HELSINKI , February 5, 2014 (press release) – Fixed asset impairments decrease depreciation by EUR 19 million quarterly and EUR 76 million annually

lStora Enso will record non-recurring items (NRI) with a negative net impact of approximately EUR 392 million on operating profit and a positive impact of approximately EUR 114 million on income tax in its fourth quarter 2013 results. The NRI will lower earnings per share by EUR 0.33.

The NRI are:

  • a negative NRI of approximately EUR 556 million due to fixed asset impairments mainly in Printing and Reading because of weakened long-term earnings expectations resulting from decline in European paper markets;
  • a negative NRI of approximately EUR 32 million due to costs related to joint-venture establishment in China, a production disruption in Renewable Packaging and settlement of a legal case with a supplier at the Group’s equity accounted investment Veracel;
  • a positive NRI of approximately EUR 179 million due to a fair valuation gain and a related provision release of EUR 7 million on the Group’s plantation assets in China;
  • a positive NRI of approximately EUR 10 million due to the Group’s share of the effect of the new tax rate on the equity accounted investment Tornator.


The positive impact of approximately EUR 114 million on the income tax comprises a positive tax impact of approximately EUR 106 million due to the operative NRIs, a positive tax impact of approximately EUR 40 million due to valuation of deferred tax assets and a negative tax impact of approximately EUR 32 million due to application of the new tax rate in Finland.

The impairment charges taken in the fourth quarter of 2013 reduce quarterly depreciation by EUR 19 million starting in the fourth quarter of 2013. Annual depreciation will decrease by EUR 76 million from 2014 onwards due to the reduced fixed asset base after the impairments.



Allocation of NRI* between segments

Segment EUR million
Printing and Reading -538
Biomaterials -8
Building and Living -
Renewable Packaging 144
Other 10
Operating Profit -392
Income tax 114
Net Profit -278
*NRI = Non-recurring items. These are exceptional transactions that are not related to normal business operations. The most common non-recurring items are capital gains, additional write-downs, or reversals of write-downs, provisions for planned restructuring and penalties. Non-recurring items are normally disclosed individually if they exceed one cent per share.

www.storaenso.com
www.storaenso.com/investors

Stora Enso is the global rethinker of the paper, biomaterials, wood products and packaging industry. We always rethink the old and expand to the new to offer our customers innovative solutions based on renewable materials. Stora Enso employs some 28 000 people worldwide, and our sales in 2012 amounted to EUR 10.8 billion. Stora Enso shares are listed on NASDAQ OMX Helsinki (STEAV, STERV) and Stockholm (STE A, STE R). In addition, the shares are traded in the USA as ADRs (SEOAY) in the International OTCQX over-the-counter market.

STORA ENSO OYJ

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.

Share:

About Us

We deliver market news & information relevant to your business.

We monitor all your market drivers.

We aggregate, curate, filter and map your specific needs.

We deliver the right information to the right person at the right time.

Our Contacts

1990 S Bundy Dr. Suite #380,
Los Angeles, CA 90025

+1 (310) 553 0008

About Cookies On This Site

We collect data, including through use of cookies and similar technology ("cookies") that enchance the online experience. By clicking "I agree", you agree to our cookies, agree to bound by our Terms of Use, and acknowledge our Privacy Policy. For more information on our data practices and how to exercise your privacy rights, please see our Privacy Policy.